Embolic Protection

Related by string. embolic protection * embolics . embolic : liquid embolics embolization coils . Embrella Embolic Deflector / PROTECTION : Health Protection Agency * distal embolic protection . embolic protection devices . embolic protection device . Embolic Protection System . Embolic Protection Device . FilterWire EZ Embolic Protection . TM Embolic Protection *

Related by context. All words. (Click for frequent words.) 75 Announces FDA Clearance 73 Drug Eluting Coronary Stent 73 FDA Approvals 73 Pivotal Clinical Trial 73 NAVISTAR R 73 Gets FDA Clearance 73 Pivotal Trial 73 Embolic Protection System 73 Thrombectomy 72 Carotid 72 Aortic Valve 72 First Patient Treated 72 TriActiv R 72 Embolic 72 Expanded Indication 72 Peripheral Arterial 71 Minimally Invasive Procedure 71 Surgical Mesh 71 Left Atrial Appendage 71 Study Evaluating 71 Embolization 71 STARFlex R 71 REMINDER ORLive Presents 71 Carotid Stent 71 PROMUS TM 71 ORLive Presents 71 TM Drug Eluting 71 Cypher Sirolimus 71 Sirolimus eluting 71 Patients Treated With 71 Drug Eluting 71 Dural Regeneration Matrix 71 Vascular Grafts 71 Patients Undergoing 71 Intravascular 70 Resurfacing System 70 AMPLATZER R 70 Less Invasive 70 Thoracic Endoprosthesis 70 Randomized Clinical Trial 70 Pivotal Study 70 Meets Primary Endpoint 70 Transcatheter 70 Image Guided Surgery 70 Microwave Ablation System 70 Non Invasive Treatment 70 Receives Orphan Drug Designation 70 Minimally Invasive Treatment 70 Clinical Trial Evaluating 70 Patient Enrollment 70 treating abdominal aortic 70 Aortic Valve Replacement 70 Spinal Implant 70 Abciximab 70 Severe Sepsis 70 Improves Survival 70 endoluminal stent graft 70 NDA Submission 70 Vascular Graft 70 Corautus Genetics 70 Dynamic Stabilization 70 Receives FDA Clearance 70 Endologix Powerlink System 70 Artificial Disc 70 FDA Clears 70 Initiates Clinical Trial 69 Bioresorbable 69 Clinical Trial Results 69 injectable bulking agent 69 Self Expanding Stent 69 Completes Enrollment 69 PROMUS R 69 Renal Artery 69 Resection 69 TM Everolimus Eluting 69 ™ Paclitaxel Eluting 69 Phase III Trial 69 Prolongs Survival 69 Completes Patient Enrollment 69 Balloon Catheters 69 Absorbable 69 Embolic Protection Device 69 Mitral Valve Repair 69 Initiates Enrollment 69 aneurysms AAA 69 Milestone Payment 69 EverFlex 69 Contrast Agent 69 Left Ventricular 69 Cardiac Resynchronization Therapy 69 Bone Void Filler 69 Phase 2a Clinical Trial 69 Hernia Repair 69 Immunotherapeutic 69 Receives CE Marking 69 Achieves Primary Endpoint 69 Fondaparinux 69 urethral bulking agent 69 Schizophrenia Treatment 69 Regenerative Cells 69 Demonstrates Significant 69 Bioabsorbable 69 Aneurysm Repair 69 Stent Graft 69 Diabetic Foot Ulcer 69 Clinical Outcome 69 Image Guided 69 Pulmonary Valve 69 Talent Abdominal 68 Flamel Technologies Announces 68 HeartMate R 68 Transdermal Delivery 68 Beta Blocker 68 TAXUS TM 68 GORE TAG 68 Catheter Ablation 68 Teva Provides Update 68 Carotid Artery Stenting 68 Stent Thrombosis 68 Intravitreal 68 Transdermal Patch 68 Edwards SAPIEN 68 Eluting Stent 68 Investigational Treatment 68 stent DES 68 Combination REOLYSIN R 68 Platinum Chromium Coronary Stent 68 Drug Coated Stent 68 Phase 2b Clinical Trial 68 Balloon Catheter 68 Stent Coating 68 Chronic Total Occlusions 68 descending thoracic 68 Submits NDA 68 Phase Ib Clinical Trial 68 Lipid Lowering 68 Microvascular 68 Drug Candidate 68 Improves Outcomes 68 renal artery stenting 68 Carotid Stenting 68 Nitinol Stent 68 Dry Powder Inhaler 68 Novel Oral 68 Phase IIb Clinical Trial 68 FDA Okays 68 Tezampanel 68 Initiate Clinical Trial 68 Contrast Enhanced 68 Robotic Assisted 68 Distal Radius 68 IND Filing 68 Files IND 68 SpideRX 68 Angiographic 68 Total Knee Replacement 68 Phase IIb Trial 68 Cholesterol Lowering Drug 67 Anti Bacterial Envelope 67 Prospective Randomized 67 Spinal Fusion 67 microcatheters 67 Phase III Clinical Trial 67 CT Angiography 67 INTELLITEMP ® 67 Excimer Laser 67 Radiofrequency Ablation 67 Percutaneous Tibial Nerve Stimulation 67 J Shoulder Elbow 67 Atherectomy 67 Evalve MitraClip R 67 refractory recurrent 67 Eluting Coronary Stent System 67 First Patient Enrolled 67 TM Embolic Protection 67 Cinacalcet 67 Myocardial Perfusion Imaging 67 Tissue Engineered 67 Ablation 67 Develop Novel 67 Occlusion 67 Shows Efficacy 67 Abdominal Stent Graft 67 paclitaxel eluting 67 Platinum Chromium 67 Initiates Clinical 67 Endovascular Treatment 67 Tissue Repair 67 Tambocor 67 FDA Clearance 67 Long Term Efficacy 67 Phase IIa Clinical Trial 67 Fungal Infections 67 Niobe ® 67 Peripheral Stent 67 Spinal Cord Stimulator 67 Stenting 67 Demonstrates Positive 67 Biolimus A9 67 Paclitaxel eluting 67 Catheter System 67 Spinal Disc 67 Osteoporosis Treatment 67 Total Knee Arthroplasty 67 Low Dose 67 Endoluminal 67 Shows Promising 67 Oral Fingolimod 67 Diastolic Heart Failure 67 Coronary Angiography 67 Neoadjuvant Chemotherapy 67 Vacuum Assisted Closure 67 Antiplatelet 67 Sirolimus Eluting Stent 67 superficial femoral 67 Medoxomil 67 Biliary System 67 Receives Approvable Letter 67 Randomized Study 67 Rheumatoid Arthritis Drug 67 Drug Eluting Stent System 67 Surgical Navigation 67 Kidney Transplant Patients 67 vapreotide acetate 67 Sleep Apnea Therapy 66 Ultrasonic Wound 66 Single Dose 66 Posaconazole 66 Lumbar Interbody Fusion 66 Phase 2b Trial 66 Bone Graft 66 Coronary Artery Bypass Graft 66 See CLINICAL PHARMACOLOGY 66 Phase 2b Study 66 Nipent R 66 Anticancer Drug 66 Bare Metal Stents 66 Mg Usa 66 ™ Everolimus Eluting 66 Cardioblate 66 Endeavor Drug Eluting 66 Thrombotic 66 MSON 66 Antimicrobial Coating 66 Vascular Closure Device 66 Patency 66 Circulatory Support 66 Hip Resurfacing System 66 Presents Preclinical Data 66 Prophylactic Treatment 66 FDA APPROVES 66 Adjuvant Treatment 66 Transcatheter Valve 66 Covered Stent 66 Measurement Devices 66 Liberte TM 66 Psoriasis Drug 66 Effectively Treats 66 Enrolls First 66 Breast Biopsy 66 Onyx Liquid Embolic 66 Renal Cancer 66 Interferon Alpha 66 Aurora Kinase 66 Ureteral 66 Clinical Trial Data 66 AneuRx 66 STENT 66 Confirmatory Phase 66 Clinical Efficacy 66 Custom NX R 66 Everolimus Eluting Coronary Stent 66 Generic Version 66 Fibrin Sealant 66 Intracranial 66 Tacrolimus 66 Tumor Growth 66 Adjuvant Chemotherapy 66 Extracellular Matrix 66 DUROS 66 PROMUS Element 66 Septal 66 received CE Conformité 66 Partial Nephrectomy 66 ATS Simulus R 66 NASDAQ BSMD medical 66 SilverHawk Plaque Excision System 66 Systemic Delivery 66 Demonstrates Sustained 66 Plaque Excision System 66 Proven Effective 66 Anastomosis 66 CentriMag 66 Shows Promise Against 66 cardiac resynchronisation therapy 66 Forward Looking IVUS 66 Phase 2a Trial 66 Pericardial 66 Regeneron Pharma 66 Endurant 66 TAXUS Express2 66 Biologics Delivery 66 GYN Surgical revenues 66 Mg Uk 66 R lenalidomide 66 Initiates Clinical Trials 66 Coronary Stent 66 Stent Restenosis 66 Combination Treatment 66 Bovie Medical 66 CORTOSS R 66 hypervascular tumors 66 HepaLife TM 66 Smooth Muscle 66 metastatic malignant 66 ExAblate R 66 Gout Drug 66 Tumor Targeting 66 Patient Outcomes 66 HuMax 66 IND Application 66 Diabetic Neuropathy 66 Secondary Hyperparathyroidism 66 GORE TAG Device 66 Immunomedics Announces 66 Milestone Payment From 66 Femtosecond Laser 66 Osteoporosis Drug 66 Direct Visualization 66 Carotid Artery 66 MR Angiography 66 Brain Metastases 66 PET Scanner 66 includes Dideco CarboMedics 66 AneuRx AAAdvantage 66 LeMaitre Vascular 66 Endoprosthesis 66 Coronary Arteries 66 Balloon Kyphoplasty 66 Oral Calcitonin 66 Peripheral vascular 66 Granted Orphan Drug 66 transurethral 65 Confirms Efficacy 65 Adhesion Barrier 65 Controlled Study 65 Intravenous Formulation 65 treat benign prostatic 65 Blood Pressure Drug 65 Patients Enrolled 65 Advanced Melanoma 65 Mylan Receives Approval 65 Oxytrol R 65 Significantly Improved 65 Generic Versions 65 Valve Replacement 65 Prostate Cancer Treatment 65 Contrast Agents 65 Heart Failure Patients 65 Taro Receives 65 Medtronic CoreValve ® 65 Orthopedic Implant 65 Anticancer Activity 65 GORE VIABAHN ® 65 Renal Impairment 65 Tyrosine Kinase Inhibitor 65 coronary stent merged 65 Bare Metal Stent 65 Treated Patients 65 DuraGen Plus 65 Synthetic Peptide 65 Epilepsy Drug 65 IV Busulfex 65 Cilostazol 65 CLiRpath 65 Percutaneous Transluminal Coronary Angioplasty 65 Adjuvant Therapy 65 Electrosurgical 65 Desvenlafaxine Succinate 65 Sirolimus eluting Coronary Stent 65 R Paclitaxel Eluting 65 Cordis Endovascular 65 Intravascular Ultrasound 65 Drug Eluting Stent 65 Knee Osteoarthritis 65 IMPELLA 65 AMPLATZER ® 65 Chemoradiation 65 Dural Sealant 65 Showed Significant 65 Antiarrhythmic 65 Small Bowel 65 Tissue Matrix 65 Drug Shows Promise 65 Peripherally Inserted Central 65 Antitumor Activity 65 Combo Therapy 65 Macroplastique ® 65 Arthritis Drug 65 Advanced Microspheres 65 Phase 1b Clinical Trial 65 Migraine Drug 65 Drug Eluting Stents 65 Inhaled Insulin 65 Novacor R 65 STARFlex ® 65 Prognostic Value 65 Implantable Cardioverter Defibrillators 65 Ultrasound Imaging 65 Treatment Naïve 65 PORT ACCESS 65 Investigational Compound 65 Novel Compound 65 GORE TAG ® 65 TRANSDUR ™ 65 Anti Angiogenic 65 RNAi Therapeutic 65 Infarct 65 Improve Survival 65 Valvular 65 Milestone Payments 65 Microplasmin 65 Stent Placement 65 Tumor Response 65 Novel Therapies 65 Therapeutic Competitors Report 65 Symptom Relief 65 Surgical Sealant 65 Vascular Imaging 65 Nicotine Vaccine 65 acute peripheral arterial 65 mechanical thrombectomy 65 PROMUS ® 65 WorldHeart Announces 65 Intra operative 65 Coronary Imaging 65 Angiotech Pharma 65 Coronary stents 65 Ancrod 65 Levoleucovorin 65 Intracranial Aneurysms 65 Osteoporosis Drugs 65 XIENCE PRIME TM 65 Abbokinase 65 Plaque Psoriasis 65 Acute Ischemic Stroke 65 Clinical Study Shows 65 HeartMate ® 65 Begins Dosing 65 ® VAD Ventricular 65 Begins Clinical Trial 65 Curon Control 65 Cardiac Ablation 65 Fracture Risk 65 Bucindolol 65 Autologous Stem Cell Transplantation 65 Renal Function 65 Aortic Aneurysm 65 HALO# [001] 65 Implantable Defibrillators 65 Investigational Oral 65 PDUFA Date 65 acetonide FA 65 Bioartificial Liver 65 Lupus Drug 65 CARTO ® 65 Microsphere 65 Nasdaq SMTS develops manufactures 65 Artery Disease 65 Patients Receiving 65 treat brain aneurysms 65 Demonstrates Potential 65 IL# PE#QQR 65 CD HORIZON 65 Restenosis 65 Platelet Inhibition 65 Pulmonary Artery 65 Significantly Improves 65 Clinical Evaluation 65 Metabolic Disorder 65 Receives Orphan Drug 65 Survival Benefit 65 Paclitaxel Eluting 65 Bone Metastases 65 Cobalt Chromium 65 TAXUS Liberté 65 JAK Inhibitor 65 Bronchoscopy 65 Inflammatory Arthritis 65 Breast Cancer Recurrence 65 Myoblast 65 Drug Absorption 65 eluting stent 65 Vaccine Adjuvants 65 Hematological Malignancies 65 XPEL Announces 65 Serostim ® 65 Dilatation 65 Alexion Pharma 65 Augment ™ 65 Begins Shipment 65 Testosterone Gel 65 Neurogenic 65 Heart Transplant Recipients 65 JAK2 Inhibitor 65 FDA Accepts 65 J Cataract Refract 64 TAXUS ® 64 Hip Implants 64 occlusion CRVO 64 PRN FDA Approves 64 Clinical Trial Enrollment 64 BioMatrix 64 Cholesterol Lowering 64 STELARA TM 64 Ozarelix 64 Articular Cartilage 64 Transcatheter Heart 64 Rheumatoid Arthritis Patients 64 Alternans 64 Adult Stem Cell Therapy 64 Stereotactic 64 WallFlex Biliary RX 64 Coherex FlatStent 64 Myocardial Ischemia 64 Revises FY# Outlook 64 Therapy Improves 64 Improved Survival 64 Biomarker Study 64 Thrombectomy System 64 Licenses Novel 64 MedPulser 64 Novel Therapeutic 64 Unfractionated Heparin 64 Ischemia 64 Skin Grafts 64 Glufosfamide 64 Mycophenolate Mofetil 64 Ischemic 64 Transdermal Drug 64 Reduces Mortality 64 Preclinical Data 64 ThromCat 64 ALVESCO ® 64 Cetuximab Erbitux 64 Reconstructive Tissue Matrix 64 Randomized Evaluation 64 Dose Escalation 64 Study Demonstrates 64 Glaucoma Treatment 64 Dual Antiplatelet Therapy 64 Sirolimus Eluting Coronary Stent 64 Treat Heart Failure 64 Sirolimus Eluting 64 Angiotensin Converting Enzyme 64 CRYO 64 Appears Safe 64 J Foot Ankle 64 percutaneous aortic valve 64 Lung Cancer Drug 64 Implantable Medical 64 Significantly Reduces 64 Progentix 64 Efficacy Trial 64 Oral Mucositis 64 Computer Aided Detection 64 Intraocular 64 Protein Expression 64 Parathyroid Hormone 64 Scintigraphy 64 Pooled Analysis 64 Preclinical Study 64 Cardiovasc 64 Alair System 64 BioSante Pharmaceuticals Announces 64 Kinase Inhibitor 64 TRANSDUR ® 64 Transdermal System 64 Eur J 64 Spinal System 64 Is Well Tolerated 64 Intravesical 64 transcranial Doppler ultrasound 64 Stent Implantation 64 Breast Biopsy System 64 Hsp# Inhibitor 64 customizable drug eluting 64 Deep Venous Thrombosis 64 Zorbtive TM 64 Alvine Pharmaceuticals 64 Macroplastique R 64 Adjunctive 64 Microcatheter 64 Express2 TM paclitaxel eluting 64 Kidney Function 64 Receives Milestone Payment 64 surgical sealant 64 Initiates Phase III 64 KL4 Surfactant 64 Assist Device 64 TAXUS Element Paclitaxel Eluting 64 Atrial Fibrillation Treatment 64 Powerlink ® 64 Bosutinib 64 Reduces Pain 64 Carotid Stent System 64 NICE Recommends 64 II Clinical Trial 64 Axxent R 64 Acute Coronary Syndromes 64 Stent Grafts 64 Anti Clotting Drug 64 Momenta Pharmaceuticals MNTA 64 Pulse Oximetry 64 Initiates Phase II 64 HER2 Positive Breast Cancer 64 Cribier Edwards 64 R Saizen R 64 Vitrectomy 64 Pivotal Phase III 64 CATANIA TM Coronary Stent 64 Post Operative 64 Medtronic CoreValve 64 Launches Generic Version 64 Dual Wavelength 64 Presents Positive 64 BOSTON SCIENTIFIC 64 ELADUR TM 64 Levaquin levofloxacin 64 Cardiac Rhythm 64 Brimonidine 64 Ozurdex 64 liver resection surgeries 64 STARFlex 64 Coronary Revascularization 64 LVAS Left Ventricular Assist 64 Hip Fractures 64 Surgical Hemostat 64 Single Photon Emission Computed 64 Delivery System NTDDS 64 Aortic Stenosis 64 Roche LightCycler ® 64 Anti Inflammatory Drug 64 Electronic Brachytherapy System 64 Emphasys Medical 64 Antithrombin 64 Vertebral Compression Fractures 64 Arch Facial Plast 64 Novel Inhibitor 64 Ascendra 64 Crit Rev 64 Orqis Medical 64 Vertebral Compression Fracture 64 Int J Obes Relat 64 GYNECARE 64 Magnetic Stimulation 64 MiniArc Precise 64 Patient Treated 64 Randomized Clinical Trials 64 Progenitor Cell 64 Ischemic Stroke 64 Dry Powder Inhalers 64 Optical Coherence Tomography 64 Submits Response 64 Teriparatide 64 Bivalirudin 64 BUPHENYL R 64 Cardiac Resynchronization 64 MEDRAD INC. 64 Occluder 64 Implantable Cardiac 64 Interferon Alfa 64 Anti Tumor Activity 64 Gene Variation 64 Cardiac Pacing 64 Ablation System 64 Minimally Invasive 64 Enlarged Prostate 64 StarClose 64 Interactive Orthopedic 64 Anticoagulant 64 Emollient Foam 64 Detection Device 64 Corindus 64 Implantable Cardioverter Defibrillator 64 Tigecycline 64 Electrical Stimulation 64 Hypercholesterolemia 64 Aloxi ® 64 Nanophase Announces 64 Myeloma Patients 64 Wafer polifeprosan 64 Européenne Mark 64 Present Preclinical Data 64 TLIF 64 Biopsy System 64 ST Elevation Myocardial 64 Resten NG 64 Infusion Pumps 64 Significantly Reduced 64 NEVO 64 Slow Progression 64 Metabasis Therapeutics 64 Spinal Cord Stimulation 64 Inhaled Nitric Oxide 64 Successfully Treats 64 Tracheostomy 64 Anti Tumor 63 Curon Medical 63 Blood Glucose Testing 63 NASDAQ BSMD 63 NexStent 63 Anticancer Agent 63 Eculizumab 63 AMPLATZER 63 Cardiac Imaging 63 ATS CryoMaze TM 63 Pedicle Screw System 63 Vascular Closure System 63 Implantable Device 63 Metastatic Renal Cell Carcinoma 63 REVELATION ® 63 endovascular stents 63 Skeletal Muscle 63 Renal Cell Carcinoma 63 Valsartan 63 Cervical Dysplasia 63 Immune Mediated 63 everolimus eluting stent 63 Prospective Multicenter 63 PROMUS Element Everolimus Eluting 63 Gastric Cancer 63 Benign Prostatic Hyperplasia 63 Aflibercept 63 Hycamtin ® 63 Hemostasis 63 Overactive Bladder 63 Bepreve TM 63 Glatiramer Acetate 63 KyphX 63 Innate Immune 63 Therapeutic Antibody 63 Lymph Node 63 Neuroendocrine Tumors 63 Sunesis Pharma 63 Robotic Catheter System 63 Testim R 63 Data Suggest 63 Soft Tissue Sarcoma 63 Ridaforolimus 63 Silodosin 63 Thrombin 63 Study Shows Significant 63 ALN HPN 63 Microspheres 63 PHASE III 63 Pulmonary Arterial Hypertension 63 Antigen Specific 63 ACE Inhibitors 63 Cardiovascular Prosthetic Devices 63 BioElectronics Corporation Announces 63 Risk Stratification 63 Varicose Vein Treatment 63 VertiFlex ® 63 INTELLITEMP ® Energy 63 VIVITROL ® 63 Attrius ™ PET 63 Repliform 63 NASDAQ POSS 63 Cardiotoxicity 63 Adenoma 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 Multidetector CT 63 transthoracic 63 Spectranetics laser 63 Visualization Equipment 63 Localized Prostate Cancer 63 Prostate Cancer Vaccine 63 catheters guidewires 63 BIOLASE Announces 63 Lung Tumors 63 Dose Ranging Study 63 Virtual Histology 63 Trial Evaluating 63 endovascular stent graft 63 Cook Zenith TX2 63 Oral Spray 63 Efficacy Results 63 Patients Treated 63 Files Patent Application 63 Interbody Fusion 63 Cholesterol Drug 63 Corneal Transplant 63 Announce License Agreement 63 Arno Therapeutics 63 Announce Collaboration Agreement 63 Recombinant Human 63 Investigational Agent 63 BrachySil ™ 63 FS Antihemophilic Factor Recombinant 63 Inflammatory Diseases 63 Interbody 63 lexidronam injection 63 osteobiologic 63 endoluminal stent graft ELG 63 Aldara ® 63 Novel Protein 63 Acute Myocardial Infarction 63 Coronary Stents 63 Non Invasive 63 Potent Antiviral Activity 63 Vascular Ultrasound 63 Breast Cancer Cells 63 Drug Prevents 63 Parenteral Nutrition 63 Anika Therapeutics 63 Novel Antibody 63 undergoing Percutaneous Coronary 63 Files Investigational 63 Acculis 63 REPRONEX R menotropins 63 saphenous vein graft 63 Global Injectables 63 RNAi Therapeutics 63 Treatment Reduces 63 Ectopic 63 Endovascular Repair 63 platelet aggregation inhibitor 63 Inc. OTCBB SPRX 63 cetuximab Erbitux R 63 cromolyn sodium 63 Electrophysiology Mapping 63 Cardiac Assist 63 RE MODEL 63 vinorelbine tartrate 63 catheter occlusion 63 Peripheral Vascular Disease 63 Angiox ® 63 Endeavor Resolute 63 Autologous 63 Protein Synthesis 63 Angiogenic 63 Cervical Spine 63 Trobalt 63 Obese Patients 63 Treatment Regimen 63 Vicriviroc 63 Aliskiren 63 Disease Progression 63 Further Validates 63 sirolimus eluting 63 HepaSphere 63 MGuard TM 63 Amplatzer 63 Receives CE 63 Cryoablation 63 Hepatocellular 63 Fluconazole 63 Vascular Wrap TM 63 Gene Variants 63 Ultrasound Guided 63 BioSTAR ® 63 Breast Brachytherapy 63 ORADUR ® 63 dual endothelin receptor antagonist 63 AERx ® 63 Announces Tentative Approval 63 Anti CD# Antibody 63 Intraocular Lens 63 Shows Statistically Significant 63 TURBO Booster 63 Finacea 63 Surgical Robot 63 Metricath Gemini 63 COVIDIEN 63 Pediatric Patients 63 Lupus Nephritis 63 Wound Closure 63 Tissue Valve 63 TAXUS Express2 Paclitaxel Eluting 63 PATHFINDER ® TRACER 63 Elderly Patients 63 Estrogen Therapy 63 ROSG 63 Fluticasone 63 TAXUS Element 63 NeoLipid R 63 J Am Coll 63 Achieves Positive 63 Announcement acc 63 Female Stress Urinary 63 Romiplostim 63 Positron Emission Tomography Computed 63 Lung Cancer Survival 63 PrandiMet 63 Pharmacokinetic Study 63 anterior lumbar interbody fusion 63 Myocet 63 SagaX 63 AnaSpec Introduces 63 Allogeneic 63 Optical Biopsy System 63 Predict Risk 63 SpineAlign 63 Patients Suffering 63 Regenerative Cell 63 HuMax Wnt 63 Lung Cancer Trial 63 Endometrial Ablation 63 Surgical Ablation 63 Fixation System 63 Advanced Colorectal Cancer 63 HER2 Positive 63 Blood Thinner 63 Blood Glucose Monitoring 63 HDAC Inhibitor 63 Adjustable Gastric Band 63 Vertebral Fracture 63 Cystectomy 63 Lowers Risk 63 MGuard ™ 63 Warfarin Coumadin 63 Ranolazine 63 Drug Fails 63 PATHFINDER R 63 Chronic Heart Failure 63 Left Ventricular Assist 63 Neurostimulation 63 Sevelamer 63 cardiac septal repair 63 Therapy Reduces 63 Monotherapy 63 Placebo Controlled Study 63 Hematologic Oncology 63 Investigational eFlow 63 Transcatheter Aortic Valve Implantation 63 Proc Am Soc 63 unfractionated heparin UFH 63 Medisorb R 63 MBRX 63 Cervical Imaging 63 ProDisc C 63 Diagnostic Tests 63 FilterWire EZ Embolic Protection 63 Commences Phase 63 thalidomide Thalomid 63 Nanoemulsion 63 Fewer Side Effects 63 Enzyme Replacement Therapy 63 Recurrent Breast Cancer 63 Randomized Trials 63 Polyzene R F 63 Proxis 63 Metastatic Prostate Cancer 63 Cell Transplants 63 Pelvic Organ Prolapse 63 Catheter Associated 63 Antiangiogenic 63 Hematopoietic 63 SYNERGY Stent 63 Volcano Therapeutics 63 IN.PACT Falcon 63 CYPHER R Sirolimus Eluting 63 ablation microcatheters 63 Epidermal Growth Factor Receptor 63 Phase 1b clinical trials 63 Fludara ® 63 Prism Pharmaceuticals 63 Robotic Catheter 63 Liprotamase 63 Hydrochlorothiazide Tablets 63 Imaging Technique 63 Nebulized 63 Neurosurg 63 TM Vascular Closure 63 Cerebral Somatic Oximeter 63 ACTOS ® 63 Nerve Targeting Drug 63 Transfection 63 Auxilium Pharma 63 Placebo Controlled Trial 63 Double Blind Placebo 63 Intracerebral Hemorrhage 63 Exogen 63 Technosphere ® 63 k Clearance 63 Study Showed 63 Hormone Refractory Prostate Cancer 63 Vascular Stent 63 Orally Active 62 Well Tolerated 62 Acute Decompensated Heart Failure 62 Gastrointestinal Liner 62 Refractory Angina 62 Venous Thromboembolism 62 CE Marked 62 Novel Vaccine 62 Genotyping Test 62 Diamyd Medical Diamyd

Back to home page